Clinical Trial Update: Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin [Phase 3]

View source ↗

Summary

Phase 3 trial comparing D961H to placebo for the prevention of gastric and duodenal ulcers in users of low-dose aspirin; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Gastric Ulcer

Drugs mentioned

• D961H

Snippet

Sponsor: AstraZeneca | Conditions: Prevention | Phase 3 | Status: COMPLETED | Results posted: 2012-11-22